In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents

N. Khardori, A. Reuben, B. Rosenbaum, K. Rolston, G. P. Bodey

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Abstract

The susceptibilities of 45 clinical and 3 environmental isolates of Xanthomonas maltophilia to 14 antimicrobial agents was determined by broth microdilution. The newer quinolones PD117596, PD117558, PD127391, A-56620, amifloxacin, and fleroxacin were the most active agents tested, with 70 to 99% of isolates being susceptible to these agents. All isolates were resistant to trospectomycin. The new aminoglycosides SCH24120 and SCH22591 were active against 12 and 1% of isolates, respectively.

Original languageEnglish (US)
Pages (from-to)1609-1610
Number of pages2
JournalAntimicrobial agents and chemotherapy
Volume34
Issue number8
DOIs
StatePublished - 1990

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'In vitro susceptibility of Xanthomonas (Pseudomonas) maltophilia to newer antimicrobial agents'. Together they form a unique fingerprint.

Cite this